CHINA PHARMA HOLDINGS, INC. (CPHI) › Capital ExpendituresCHINA PHARMA HOLDINGS, INC. (CPHI) — Capital ExpendituresAnnual figures by period end, from SEC filings.2010-12-31: -$63.9K2011-12-31: -$352.4K2012-12-31: -$156.9K2013-12-31: -$18.79M2014-12-31: $5.13M2015-12-31: -$685.3K2016-12-31: $193.4K2017-12-31: $136.5K2018-12-31: $51.1K2019-12-31: $136.0K2020-12-31: $867.3K2021-12-31: $438.1K2022-12-31: $402.0K2023-12-31: $11.5K2024-12-31: $38.4K2025-12-31: $59.3K$59.3K2010-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$59.3K+54.4%2026-04-01From 2025-01-012024-12-31$38.4K+233.5%2026-04-01From 2024-01-012023-12-31$11.5K-97.1%2025-03-31From 2023-01-012022-12-31$402.0K-8.2%2023-03-30From 2022-01-012021-12-31$438.1K-49.5%2023-03-30From 2021-01-012020-12-31$867.3K+537.7%2022-03-30From 2020-01-012019-12-31$136.0K+165.9%2021-03-26From 2019-01-012018-12-31$51.1K-62.5%2020-03-30From 2018-01-012017-12-31$136.5K-29.4%2019-03-28From 2017-01-012016-12-31$193.4K—2018-04-02From 2016-01-012015-12-31-$685.3K-113.4%2017-03-31From 2015-01-012014-12-31$5.13M—2016-03-30From 2014-01-012013-12-31-$18.79M—2015-12-28From 2013-01-012012-12-31-$156.9K—2014-03-20From 2012-01-012011-12-31-$352.4K—2013-03-14From 2011-01-012010-12-31-$63.9K—2012-03-14From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)